Prete M - Search Results

1

Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysis.

Perosa F, Luccarelli G, Prete M, Indiveri F, Dammacco F. Perosa F, et al. Among authors: prete m. Clin Exp Med. 2001 Jun;1(2):81-9. doi: 10.1007/s10238-001-8016-1. Clin Exp Med. 2001. PMID: 11699732

2

Non-Classical HLA Class 1b and Hepatocellular Carcinoma.

De Re V, Tornesello ML, Racanelli V, Prete M, Steffan A. De Re V, et al. Among authors: prete m. Biomedicines. 2023 Jun 9;11(6):1672. doi: 10.3390/biomedicines11061672. Biomedicines. 2023. PMID: 37371767 Free PMC article. Review.

3

Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma.

Leone P, Solimando AG, Prete M, Malerba E, Susca N, Derakhshani A, Ditonno P, Terragna C, Cavo M, Silvestris N, Racanelli V. Leone P, et al. Among authors: prete m. Cells. 2023 Mar 25;12(7):1011. doi: 10.3390/cells12071011. Cells. 2023. PMID: 37048084 Free PMC article.

4

Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department.

Lisco G, Solimando AG, Stragapede A, De Tullio A, Laraspata C, Laudadio C, Giagulli VA, Prete M, Jirillo E, Saracino A, Racanelli V, Triggiani V. Lisco G, et al. Among authors: prete m. Endocr Metab Immune Disord Drug Targets. 2024;24(10):1224-1236. doi: 10.2174/0118715303288042240111070057. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38243977 Free PMC article.

5

Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma.

Perosa F, Luccarelli G, Prete M, Ferrone S, Dammacco F. Perosa F, et al. Among authors: prete m. Br J Haematol. 1999 Sep;106(4):987-94. doi: 10.1046/j.1365-2141.1999.01635.x. Br J Haematol. 1999. PMID: 10520002 Free article.

6

Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype.

Perosa F, Prete M, Luccarelli G, Favoino B, Ferrone S, Dammacco F. Perosa F, et al. Among authors: prete m. Hum Immunol. 1999 Nov;60(11):1058-66. doi: 10.1016/s0198-8859(99)00081-6. Hum Immunol. 1999. PMID: 10600003

7

Monoclonal antibodies in the immunotherapy of autoimmune diseases.

Perosa F, Luccarelli G, Prete M, Dammacco F. Perosa F, et al. Among authors: prete m. Ann Ital Med Int. 2001 Oct-Dec;16(4):220-32. Ann Ital Med Int. 2001. PMID: 11799630 Review.

8

Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression.

Perosa F, Prete M, Luccarelli G, Favoino B, Dammacco F. Perosa F, et al. Among authors: prete m. Eur J Immunogenet. 2002 Oct;29(5):409-12. doi: 10.1046/j.1365-2370.2002.00343.x. Eur J Immunogenet. 2002. PMID: 12358850

9

Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma.

Perosa F, Prete M, Luccarelli G, Dammacco F. Perosa F, et al. Among authors: prete m. Br J Haematol. 2003 Jan;120(1):36-43. doi: 10.1046/j.1365-2141.2003.03945.x. Br J Haematol. 2003. PMID: 12492574 Free article.

10

The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma.

Dammacco F, Luccarelli G, Prete M, Silvestris F. Dammacco F, et al. Among authors: prete m. Rev Clin Exp Hematol. 2002;Suppl 1:32-8. Rev Clin Exp Hematol. 2002. PMID: 12735213 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters